NOVIGENIX SA
Company Snapshot
Company Overview
Novigenix is a cutting-edge precision medicine company that provides liquid biopsy multi-omic solutions driven by the LITOSeek AI-RNA analytics platform. Novigenix generates exact information on the patient’s reaction to cancer, the disease’s progression, and the response to therapy by analyzing vast volumes of RNA data from the blood of various patients. The company’s proprietary Immuno-Transcriptomics LITOSeek platform, which has been optimized and standardized for integrating patient multi-omics data with cutting-edge Machine Learning and artificial intelligence approaches, is used in Novigenix solutions, which use state-of-the-art molecular technologies ranging from NGS to RT-PCR based platforms to map the immune system’s response to the onset and progression of disease.
Company's Business Segments
- Products : Immuno Transcriptomics, LITOseek platform, Others
- Services : Prevention through early detection of cancer, Precision Medicine, Innovative Drug Target Discovery
Applications/End User Industries
- Healthcare
- Pharmaceutical
- Biotechnology
- Research Institution
